Etiome emerges with $50M from Flagship Pioneering and goal of preempting disease

A new biotech is hitting the Boston scene with $50 million from Flagship Pioneering and a goal of preventing patients from ever getting seriously ill in the first place.

Apr 24, 2025 - 12:03
 0
Etiome emerges with $50M from Flagship Pioneering and goal of preempting disease
A new biotech is hitting the Boston scene with $50 million from Flagship Pioneering and a goal of preventing patients from ever getting seriously ill in the first place.